Lv5
890 积分 2025-05-12 加入
Efficacy and safety of gefapixant, a P2X(3) receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
29天前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
1个月前
已完结
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
1个月前
已完结
Deciphering the prodrome of inflammatory bowel disease up to 10 years before disease onset by massively parallel serology
1个月前
已完结
The impact of ventilation rate on the fungal and bacterial ecology of home indoor air
1个月前
已完结
Metabolomic profiles of body shapes and their associations with the risk of incident cardiovascular disease in Chinese adults
4个月前
已完结
Relation of Platelet Parameters With Incident Cardiovascular Disease (The Dongfeng-Tongji Cohort Study)
4个月前
已完结
Bedtime, sleep pattern, and incident cardiovascular disease in middle-aged and older Chinese adults: The dongfeng-tongji cohort study
4个月前
已完结
Associations of coagulation factor X and XI with incident acute coronary syndrome and stroke: A nested case‐control study
4个月前
已完结
Hearing loss is associated with increased stroke risk in the Dongfeng-Tongji Cohort
4个月前
已完结
皖公网安备34019202002308
